ASH 2021 Recap: Multi Omics Sheds New Light on Malignant Transformation from Myeloproliferative Neoplasm to AML
Link above leads to podcast recording.
IMPORTANT: UPDATED Guidance for Patients on COVID-19 including Vaccine Information»
Link above leads to podcast recording.
Understanding Low Risk MDS 2021 Winter Patient Family Conference
Adrienne Phillips, MD, MPH
Understanding Aplastic Anemia 2021 Winter Patient Family Conference
Anna Koget, DO
Understanding Low Risk MDS 2021 Fall Patient Family Conference
Suresh Balasubramian, MD, Karmanos Cancer Center
Understanding Aplastic Anemia 2021 Fall Patient Family Conference
Daria Babushok, MD, PhD, Penn Medicine
Managing the Side Effects of Bone Marrow Failure - Summer 2021 Conference
Eric Padron, MD, Moffitt Cancer Center
Diagnosing Bone Marrow Failure Diseases - Summer 2021 Conference
Amy Duffield, MD, PhD, Memorial Sloan Kettering
8th Seattle Patient Conference: Ask an Expert
H. Joachim Deeg, MD
8th Seattle Patient Conference - Living Well with MDS/MPN
Krisstina Gowin, DO, University of Arizona
Jason Harold Mendler, MD, PhD, Assistant Professor of Oncology, received his bachelor's degree, Summa Cum Laude, from Washington University in St. Louis, Missouri. He then went on to earn his PhD in Genetics and his medical degree at the University of Rochester School of Medicine and Dentistry in Rochester, New York. Prior to joining Wilmot Cancer Center, Dr. Mendler completed his residency at and served as chief resident of the University of Rochester Medical Center, Department of Medicine.
